The IV equipment market encompasses the medical technology sector focused on manufacturing and distributing devices, instruments, and supplies used to deliver fluids, medications, blood products, and nutrients directly into a patient’s bloodstream. It spans products like IV catheters, infusion pumps, and administration sets used across acute, chronic, and long-term care settings.
The global IV equipment market was valued at USD 16.85 billion in 2025 and USD 17.82 billion in 2026, and it is projected to reach USD 23.92 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.1%.
Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78345313
The IV equipment industry market is primarily driven by the rising global prevalence of chronic illnesses like cancer and diabetes, an aging population, increasing surgical procedures, and technological innovations in smart infusion pumps that reduce medication errors. However, market expansion is heavily restrained by strict regulatory approval frameworks for new products, frequent medication errors, and persistent risks of catheter-related bloodstream infections. Lucrative opportunities exist in the surging demand for home infusion therapy and ambulatory care models, alongside the growing adoption of eco-friendly, non-PVC, and DEHP-free materials. Despite these prospects, the market faces key challenges, including strong pricing pressure from institutional buyers and group purchasing organizations, equipment malfunctions, and a global shortage of skilled infusion nurses.
The target customers for the IV equipment industry market primarily encompass institutional healthcare providers—such as public and private hospitals, clinics, ambulatory surgical centers, and emergency care facilities—alongside an expanding segment of home healthcare providers and caregivers. These customers need high-volume, medical-grade devices including IV catheters, infusion pumps, and administration sets to manage high-acuity treatments, surgeries, and long-term chronic conditions like cancer and diabetes. They demonstrate a strong preference for advanced, safety-engineered solutions that feature technological innovations, such as smart infusion systems, needle-free connectors, and antimicrobial coatings designed to prevent healthcare-associated infections and reduce dosage errors. Their purchasing behavior is highly structured, clinical, and volume-driven, anchored in rigorous regulatory compliance, institutional budgeting, and centralized procurement systems, while increasingly shifting toward scalable and compact, user-friendly models to support the rising demand for outpatient and home-based clinical care.
Market entry, expansion, and profitability in the IV equipment industry market are heavily shaped by stringent regulatory compliance frameworks, rapid technological integration, and distinct economic pressures. Regulators enforce strict quality standards and safety guidelines to mitigate the risk of catheter-related infections, where securing approvals ensures patient trust but can delay market entry. Technologically, the integration of smart infusion pumps with AI-enabled dose error reduction systems, wireless remote monitoring, and safety-engineered needleless connectors is transforming clinical workflows, driving rapid uptake in both institutional and home healthcare settings. Economically, while an aging global population and rising chronic disease burdens ensure sustained long-term demand, manufacturers face strong pricing pressure from institutional buyers, high initial capital investments, and severe supply chain fragilities—such as localized manufacturing disruptions that trigger critical shortages of sterile fluids and raw materials—which pose significant risks to ongoing profitability.
The IV equipment market is experiencing a significant transformation, shifting from traditional hospital-based delivery methods to alternative settings like home care, ambulatory surgery centers, and outpatient infusion centers. Current and emerging trends are heavily centered on technological advancements and patient safety, driving strong demand for smart infusion systems, closed-system and safety-engineered catheters, portable ambulatory devices, and IV sets equipped with digital monitoring. Providers are increasingly prioritizing precise dosing, error reduction, infection prevention, and seamless electronic health record (EHR) integration. These trends are evolving rapidly to meet changing healthcare delivery models, as highlighted by the steady growth of the global market—projected to expand at a compound annual growth rate (CAGR) of 6.1% from 2026 to 2031—with specialized segments like smart infusion pumps and home-care settings expanding even faster at individual CAGRs of 6.67% and 6.97% respectively.
Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78345313
Technological innovations disrupting the IV equipment market are centered on safety, digitization, and precision, driven primarily by the adoption of smart infusion pumps featuring advanced software algorithms, dose error reduction systems, and cloud analytics. The integration of IoT-enabled systems and electronic health records allows real-time remote monitoring, data analytics, and predictive maintenance, enhancing clinical decision-making. Significant traction is also being gained by safety-engineered devices, such as needle-free connectors, closed system transfer devices, and automatic line-flushing devices, which minimize needlestick injuries and cross-contamination. Furthermore, the industry is witnessing a material shift toward portable ambulatory infusion devices that support home healthcare models, alongside the development of sustainable, non-PVC, and DEHP-free IV packaging materials like ethylene vinyl acetate to mitigate chemical leaching risks.
In the IV equipment market, short-term trends are primarily driven by temporary procurement surges and episodic supply-chain disruptions, such as the localized plant shutdowns that trigger immediate fluid shortages and force hospitals to make tactical, near-term usage adjustments. Conversely, long-term structural shifts are firmly anchored in permanent clinical advancements, demographic pressures, and evolving healthcare delivery models. These enduring transformations include a widespread transition from traditional hospital environments to home healthcare, ambulatory care, and outpatient infusion settings, which heavily accelerates the adoption of portable, smart infusion pumps featuring digital monitoring, automated dose-error reduction systems, and seamless electronic health record integration. Furthermore, institutional shifts toward stringent infection control and safety regulations ensure a permanent, recurring demand for sterile, single-use disposables, needleless connectors, safety-engineered catheters, and sustainable non-PVC packaging to mitigate chemical leaching and minimize hospital-acquired infections.
Source:https://www.marketsandmarkets.com/Market-Reports/iv-equipment-market-78345313.html
